Business · 24/09/2019Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for MED-EL EAS Hearing Prosthesis System
Summary
The US Food and Drug Administration (FDA) has officially approved the regulatory review period for MED-EL Electric and Acoustic Stimulation Hybrid Hearing Prosthesis System, a medical device, following a patent extension application submitted to the US Patent and Trademark Office (USPTO).
Original source language: Federal Register — Food and Drug AdministrationOpen original release →